Navigation Links
Cataleng Announces New Optimized Drug Delivery Technologies at CPhl Worldwide/ICSE
Date:10/23/2013

Somerset, NJ & CPhI Worldwide/ICSE, Frankfurt, Germany (PRWEB) October 23, 2013

Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that it is introducing several new drug delivery technologies at CPhI Worldwide/ICSE (Messe Frankfurt, Frankfurt, Germany 21-24 October 2013, Hall 4.2), all of which may offer delivery solutions and important IP advantages to drug manufacturers.

Catalent announced two new RP Scherer Softgel offerings to help develop more molecules into better treatments for patients. The first, OptiGel LockTM, is designed to prevent the abuse of prescription pain medications, and the deliberate misuse of consumer pseudoephedrine products. Developed in response to regulatory demands for alternative technologies that might deter abuse, this new softgel delivery technology incorporates several levels of deterrent into a single formulation designed to prevent extraction of the active substance.

Also new is OptiGel BioTM, which may enable certain macromolecules to be delivered orally and overcome permeability and stability challenges in a more easily administered form than injection. OptiGel Bio may improve the permeability of large molecule APIs, while also enabling targeted delivery to be achieved via an enteric coating. This protective coating eliminates degradation of the encapsulated formulation in the stomach. Patient advantages may include reduced dosing complexity, improved safety and better adherence.

Finally, OptiGel MiniTM technology enables the creation of capsules that are approximately 30% smaller and yet accommodate the same amount of active ingredients as conventional softgel capsules, providing a substantial benefit over many prescription and consumer health products and making them easier for the patient or consumer to swallow. Following the recent introduction of OptiShell™ technology, to provide solutions for complex semi-solid lipid-based formulations, Catalent continues to innovate by delivering advanced drug delivery technologies, bioavailability solutions and versatile and proven softgel technologies.

In addition, Catalent announced two new technologies under its proprietary Zydis® Oral Fast Dissolve Technology platform. Zydis BioTM may help deliver large molecules such as proteins, peptides, viral vaccines and allergens in a patient preferred oral fast dissolve format in as little as three seconds. Zydis NanoTM technology is designed to improve bioavailability of compounds in a fast dissolve format.

Catalent will also be discussing new OSDrC® OptiDose™ advanced tableting technology for multiple release profiled (pulsatile, immediate release and extended release ) and combination products at CPhI, as well as its next generation antibody drug conjugation (ADC) technology for Biologics – SMARTag™.

“These innovations underline Catalent’s commitment to constantly bringing new products to market faster, with the ultimate goal of providing better treatments to patients, in the most effective manner,” commented Kurt Nielsen, Senior Vice President, Catalent R&D. “Whether deterring substance abuse, providing an alternative to injection, or improving compliance and adherence, our new technologies deliver significant benefits to developers, marketers and end users.”

About Catalent
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2013/10/prweb11260388.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Los Angeles Drug & Alcohol Detox Center Announces No-Cost Consultations for Individuals Seeking Drug & Alcohol Detoxification Services
2. MinuteHound Announces Latest Biometric Time Keeping System Designed for Hospitals and Patient Clinics
3. Air-Care Announces New Version of Air-Care Pro Software
4. Spicy Lingerie Announces Most Popular Costumes for 2013
5. Marina Del Rey Hospital Announces the Acquisition of Brainlab’s Curve Image-Guided Surgery Platform and 3D C-Arm Navigation Software
6. Science Museum of Virginia Announces $1 Million Gift from Altria Group to Develop Out-of-School Time STEM Initiative
7. Core Solutions Announces New Headquarters to Accommodate Growth
8. Rapid Insight Announces Dynamic Online Learning Series for Predictive Analytics
9. Diet Doc Hormone Diets & Weight Loss Plans Announces New Diet Plans for Women of all Ages that Melt Old, Trapped and Stored Fat
10. Steaz® Announces Two New Executive Appointments: Ralf Lottermann as Chairman and Linda Barron as Chief Executive Officer
11. Miraca Life Sciences Announces That It Has Acquired PLUS Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... According to recent statistics, there are nearly half a million physical ... Each physical therapy professional and every clinic has a duty to perform at the ... a competitive industry is also essential. The solution that many physical therapy leaders turn ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... FDAI, DAHC, CDC, has joined the Fire Door Solutions’ team. Keith will ... fire door and frame in-field re-labeling. He will be instrumental in developing ...
(Date:5/31/2016)... ... ... More than 80 representatives of the Hepatitis B Foundation , Hepatitis ... an event on National Hepatitis Testing Day outside of Philadelphia City Hall to raise ... of liver cancer. , Foundation leaders and the citywide coalition they created, Hep B ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two hospital ... patients from other participating organizations in the exchange. SJMC’s membership in the health ...
(Date:5/31/2016)... Beach, Florida (PRWEB) , ... May 31, 2016 ... ... to Jay Butch of CertainTeed Corporation, he knew it was something that contractors ... as state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director of Contractor ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... ORANGE COUNTY, Calif. , May 27, 2016  A new study highlights the ... study conducted by the  Journal of the American College of Radiology , a majority ... particular procedures. Photo - http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic ...
(Date:5/27/2016)... , May 27, 2016 ... instances of hypertension is driving ambulatory blood pressure monitoring ... their elasticity and their ability to respond to different ... This condition can lead to various cardiovascular disorders such ... vascular disease. These diseases are growing in prevalence each ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
Breaking Medicine Technology: